...
首页> 外文期刊>Journal of gastrointestinal cancer. >Primary Clear Cell Carcinoma of the Non-cirrhotic Liver Presenting as an Acute Abdomen: a Case Report and Review of the Literature
【24h】

Primary Clear Cell Carcinoma of the Non-cirrhotic Liver Presenting as an Acute Abdomen: a Case Report and Review of the Literature

机译:非肝硬化肝脏的初级透明细胞癌作为急性腹部:案例报告和文学审查

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Introduction: Hepatocellular carcinoma (HCC) is the sixth most common cancer in the world [1, 2]. The incidence of hepatocellular carcinoma in Northern America in 2008 was 6.8 in males and 2.2 in females [3]. The major risk factors for the development of HCC include alcohol abuse, infection with hepatitis B virus (HBV) or hepatitis C virus (HCV), and non-alcoholic steatohepatitis (NASH) [4]. Other less common causes include autoimmune hepatitis, alpha 1-antitrypsin deficiency, he-mochromatosis, and Wilson's disease [4]. Primary clear cell carcinoma of the liver (PCCCL) is a rare histologic variant of HCC, with frequencies ranging from 0.4 to 37 % [5-8]. The majority of patients with PCCCL are over the age of 50 and have cirrhosis of the liver [7]. The strongest risk factor for PCCCL is HCV infection, with no significant associations with alcohol abuse, HBV infection, NASH, hemochromatosis, or autoimmune liver diseases [7, 9]. PCCCL is characterized by large vacuolated tumor cells with clear cytoplasm that do not stain with hematoxylin and eosin [10, 11]. PCCCL is diagnosed when the proportion these clear cells in the tumor is >50 %, comparing to benign hepatocytes [5-7]. This tumor poses a diagnostic challenge since it has many morphologic similarities to extrahepatic clear cell carcinomas of renal, adrenal, ovarian, pancreas, lungs, and other organs [10, 12]. It is important to distinguish PCCCL from other metastatic clear cell carcinomas as their treatment modalities and prognosis are different [6, 7]. Here, we describe a case of PCCCL, who presented with acute abdomen. The incidence, risk factors, diagnosis, and management of this rare clinical entity are discussed.
机译:介绍:肝细胞癌(HCC)是世界上第六次常见的癌症[1,2]。 2008年北方肝细胞癌的发病率为6.8,女性为6.8,女性为2.2 [3]。 HCC发展的主要危险因素包括酗酒,乙型肝炎病毒(HBV)或丙型肝炎病毒(HCV)的感染,以及非酒精性脱脂性炎(NASH)[4]。其他少的常见原因包括自身免疫性肝炎,α1-抗抗核蛋白缺乏,He-Mochromatosis和威尔逊的疾病[4]。肝脏(PCC1)的初级透明细胞癌是HCC的稀有组织学变体,频率范围为0.4至37%[5-8]。大多数患有PCC10的患者患者50岁,肝硬化[7]。 PCC1的最强大的危险因素是HCV感染,没有与酒精滥用,HBV感染,肿瘤,血细胞瘤或自身免疫肝病的重要关联[7,9]。 PCCC1的特征在于大型真空肿瘤细胞,具有透明细胞质,不会用苏木精和曙红[10,11]染色。当肿瘤中这些透明细胞的比例为50%时,诊断出PCC1,与良性肝细胞相比[5-7]。这种肿瘤造成诊断挑战,因为它具有许多与肾,肾上腺,卵巢,胰腺,胰腺,肺等器官和其他器官的脱皮细胞癌进行了许多形态的相似性[10,12]。重要的是要区分PCC1与其他转移性透明细胞癌,因为它们的治疗方式和预后是不同的[6,7]。在这里,我们描述了患有急性腹部的PCCC1的情况。讨论了这种罕见的临床实体的发病,危险因素,诊断和管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号